- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)
Research supplier
Pienomial Inc.
Pienomial Inc. is listed as a small business research supplier in the Scientist.com network, with 2 sites in 2 countries.
View Pienomial Inc. on Scientist.com
Email me this page as a PDF
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Sites
2
Countries
2
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: Small business
Clinical Consulting
- Clinical Protocol Design & Development Creation of clinical protocol document which details how a clinical trial is designed, relating to to the methodology, hypothesis, and operation of clinical trial to ensure the safety of the patients is...
- Clinical Trial Consulting Consulting services for Clinical trials.
- Regulatory Compliance & Documentation Regulatory compliance describes the goal that organizations aspire to achieve in their efforts to ensure that they are aware of and take steps to comply with relevant laws, policies, and regulations.
- Study Budgeting Consulting Request for Consulting Services
Commercial Consulting
- Portfolio Management Manage a portfolio of projects in early-stage drug discovery and provide factors that determine the success of the proposed portfolio.
Data Science/Bioinformatics
- RWE/HEOR Machine Learning/AI Complex analytical approaches to find patterns and make predictions in RWE/HEOR projects
- RWE/HEOR Market Analysis A process to understand how a drug is performing in the market and possible opportunities in the market
- RWE/HEOR Software Tools Software designed to serve the needs of RWE/HEOR research groups.
Drug Development
- Consulting Services Work with consultants who provide expert advice in various areas of research and technology.
HEOR
- Burden of Illness/Disease Strategy and study related to assessing the impact (economic, non-economic) of disease on health outcomes in a country, region, community, patient, or health system.
- Health Economics and Outcomes Research (HEOR) Evaluate data collected during drug development to maximize the value of a therapeutic product.
- Resource Utilization Descriptive and/or analytical review of a treatment that investigate the marketing, distribution, prescription, and use of drugs in populations. Endpoints to be assessed are the medical, social, and economic outcomes.
- Systematic Literature Review Summarizes the results of research (that meet pre-defined eligibility criteria for inclusion) and provides a high level of evidence on the outcomes assessed.
Show all 44 services
Market Access
- Emerging Market Opportunities Analyze risks and opportunities in new markets and ensure patients have timely and continued access to new treatments.
- Environmental Analysis Research or strategy related to understanding the market (size, competition, reimbursement, challenges, etc.) and is a tool used to understand if a product can be launched in the market.
- Health Technology Assessment (HTA) Preparation/Strategy Dossier Development Perform evidence preparation and/or create strategies for the systematic evaluation of the properties, effects, and/or impacts of health care technology.
- Health Technology Assessment Submission (HTA Submission) Analyze the medical, social, ethical, humanistic, and economic considerations of a drug, medical device, or clinical procedures. Submissions are sent to regulatory agencies with different requirements that govern...
- Life Science Reports Life Science reports
- Market Access - HTA Landscape Assessment Conduct a HTA landscape assessment to evaluate the direct and indirect impact of health technology on a specific region.
Show all 12 in Market Access
- Market Research & Business Intelligence Run market feasibility studies, establish customer needs, improve product performance and analyze competition.
- Marketing and Commercialization Identify, promote and prove the value of a particular drug to key stakeholders.
- Pharmaceutical Reports Pharmaceutical Reports
- Pricing Strategy Develop value story tailored to a payer audience that will determine the appropriate price for treatment.
- Study Start Up Consulting Request for RWE/HEOR/Market Access Study Start Up Consulting
- Value Dossiers Development Summary document that presents clinical, economic, and humanistic value of an intervention and associated disease state with the supporting evidence, formulated from the perspective of a particular stakeholder...
Medical Communications
- Advisory Boards Logistical and content support for organizing panels of external experts to gather critical strategic insights and feedback on therapeutic and product development plans.
- Competitive Intelligence Develop a coordinated competitive intelligence program which contains a systematic collection and analysis of information from multiple sources about a specific business's industry.
- Faculty and/or Steering Committee Management Oversight and compliant coordination of expert groups involved in clinical trials, publication steering, or educational program development.
- HCP Recruitment Compliant identification and engagement of appropriate healthcare professionals (HCPs) for advisory boards, speaker programs, or clinical trial participation.
- HEOR/Value Publications Writing and submission of manuscripts and abstracts focusing on Health Economics and Outcomes Research (HEOR) data, which demonstrate the economic and value proposition of a therapy.
- KOL Engagement & Management Building and maintaining compliant, value-driven relationships with Key Opinion Leaders (KOLs) to collaborate on scientific exchange and clinical education initiatives.
Show all 9 in Medical Communications
- Landscape Analysis Find a cohesive and consistent view of your main organization. Develop initiatives in analyzed areas of operations and analyze chosen key aspects of them.
- Market & Competitor Analyses Evaluating the current therapeutic landscape, identifying unmet needs, and assessing the scientific positioning and data of competitor products.
- Medical Writing and Editing/Manuscript Development Communicate scientific, technical and health-related information to a range of audiences.
Old Category HEOR, RWE, Market Access
- RWE/HEOR/Market Access Disease/Clinical Outcomes Study the course of disease and the possible outcome of disease, including expected frequency.
- RWE/HEOR/Market Access Hybrid Study Combine different methodologies (retrospective, prospective, registries, chart or claims review, electronic medical/health records) to gain insights into real world patient behavior or drug use.
Primary Market Research
- Competitive Landscape Research Maps competitor products, positioning, trial activity, and perception among stakeholders. Delivers inputs for SWOT analysis and differentiation strategy.
- Payer and HTA Expectations Research Engages payers and HTA bodies to uncover evidence needs, pricing thresholds, and access drivers. Informs clinical and economic evidence generation planning.
- Persona Development Synthesizes qualitative and quantitative data to build detailed, actionable profiles of stakeholder archetypes. Supports targeted communications and segmentation strategies.
Real World Evidence & Data
- Clinical Data Registry A study or collection of data regarding the health of patients and the care they receive over different time periods.
- Predictive Analytics Variety of statistical techniques from data mining, predictive modeling, and machine learning, that analyze current and historical facts to make predictions about future or otherwise unknown events.
- Real-World Data Acquire real-world data from patients' electronic medical records including clinical information generated during the course of healthcare.
- RWE/HEOR/Market Access Safety Surveillance Monitor safety of treatment and determine methods to identify adverse events early
Regulatory Affairs
- Life Cycle Management Plan and strategy of the data collection and information throughout the different phases of product development (portfolio assessment, pre-clinical trials, clinical trials, pre-authorization, post-authorization, and RWE)
- Website
- www.pienomial.com
Where it operates
Sites by country, with the cities in each.
-
India 1 site
-
United States 1 site
Supplier diversity
SAM.gov small-business designations
Minority-owned
US small-business federal-contractor designation, self-certified in the U.S. federal System for Award Management (SAM.gov). Coverage is limited to matched U.S. small-business suppliers, so an absent designation is not evidence of its absence.
Work with Pienomial Inc. on Scientist.com
For prices, more details, or to contact Pienomial Inc., visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.